Anacalypsis Therapeutics
PrivateLast Round
Pre Seed
Sep 21, 2026
Total Funding Raised
$344,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Anacalypsis Therapeutics is a biotechnology company developing differentiated therapeutic strategies and biomarker technology for Parkinson's disease and related neurodegenerative disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anacalypsis Therapeutics Comparables
Compare Anacalypsis Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kifa Therapeutics | 81% | |
| SciNeuro Pharmaceuticals | 77% | |
| Neuron23 | 77% |
Anacalypsis Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Sep 21, 2026 |
Key People
Founding team and executive leadership
Anacalypsis Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Metavallon | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 21, 2026
$344K round led by Metavallon
Anacalypsis Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Anacalypsis Therapeutics's valuation, stock price, and market status.
Is Anacalypsis Therapeutics a public or private company?
Anacalypsis Therapeutics is a private company.
What is the current stock price of Anacalypsis Therapeutics?
Anacalypsis Therapeutics is a private company with no public stock price. Caplight tracks Anacalypsis Therapeutics's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Anacalypsis Therapeutics worth (valuation)?
Valuation information for Anacalypsis Therapeutics is not publicly available.
Can I buy Anacalypsis Therapeutics stock?
Anacalypsis Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Anacalypsis Therapeutics's last funding round?
Anacalypsis Therapeutics's most recent funding round was Pre Seed on September 21, 2026.
Who are the main investors in Anacalypsis Therapeutics?
Key investors in Anacalypsis Therapeutics include Metavallon.
Will Anacalypsis Therapeutics IPO soon?
No public IPO plans have been announced for Anacalypsis Therapeutics.
How can I track Anacalypsis Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anacalypsis Therapeutics's secondary market activity and sign up for updates.